Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway

• Main Authors: Chongyang Ma (Author), Xueqian Wang (Author), Tian Xu (Author), Xue Yu (Author), Shuang Zhang (Author), Shuling Liu (Author), Yushan Gao (Author), Shuning Fan (Author), Changxiang Li (Author), Changming Zhai (Author), Fafeng Cheng (Author), Qingguo Wang (Author)
• Formato: Livro
• Publicado em: BMC, 2019-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Cerebral ischemia is the second-leading cause of death and the main cause of permanent adult disabilities worldwide. Qingkailing (QKL) injection, a patented Chinese medicine approved by the China Food and Drug Administration, has been widely used in clinical practice to treat cer...